Modulation of NAD (P) H:Quinone Oxidoreductase (NQO1) Activity Mediated by 5-Arylamino-2-methyl-4,7-dioxobenzothiazoles and their Cytotoxic Potential

Archives of Pharmacal Research

Volumn 23, Issue 6, 2000, Pages 554-558

  Ryu, Chung Kyu ^a   Jeong, Hyeh Jean ^a   Lee, Sang Kook ^a   Kang, Hye Young ^a   Ko, Kyung Min ^a   Sun, Yang Jung ^a   Song, Eun Ha ^a   Hur, Yeon Hoe ^a   Lee, Chong Ock ^b  

^a Ewha Womans University   (South Korea)

^b Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; ECHINOMYCIN; ENZYME INHIBITOR; QUINOMYCIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); THIAZOLE DERIVATIVE;

ARTICLE; CELL CULTURE; DRUG ANTAGONISM; DRUG SCREENING; HUMAN; SYNTHESIS;

ANTINEOPLASTIC AGENTS; DRUG SCREENING ASSAYS, ANTITUMOR; ECHINOMYCIN; ENZYME INHIBITORS; HUMANS; NAD(P)H DEHYDROGENASE (QUINONE); QUINONE REDUCTASES; THIAZOLES; TUMOR CELLS, CULTURED;

EID: 0034567175     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02975239     Document Type: Article

References (13)

1. Beall, H. D., Liu, Y., Siegel, D., Bolton, E. M., Gilson, N. W. and Ross, D., Role of NAD(P)H: quinone oxidoreductase (DT-diaphorase) in cytotoxicity and induction of DNA damage by streptonigrin. Biochem. Pharmacol., 51, 645-652 (1996).
2. Beall, H. D., Murphy, A. M., Siegel, D., Hargreaves, R. H. J., Butler, J. and Ross, D., Nicotinamide adenine dinucleotide (Phosphate): Quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: quinone cytotoxicity and selectivity in human lung and breast cancer cell lines. Mol. Pharmacol., 48, 499-504 (1995).
3. Bradford, M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein-dye binding. Anal. Biochem., 72, 248-254 (1976).
4. Ernster, L., DT-diaphorase. Methods Enzymol., 10, 309-317 (1967).
5. Fryatt, T., Goroski, D. T., Nilson, Z. D., Moody, C. J. and Beall, H. D., Novel quinolinequinone antitumor agents: structure-metabolism studies with NAD(P)H: quinone oxidoreductase (NQO1). Bioorg. Med. Chem. Lett., 9 (15), 2195-2198 (1999).
6. Lee, S. K., Cui, B., Metha, R. R., Kinghorn, A. D. and Pezzuto, J. M., Cytostatic mechanism and antitumor potential of novel 1H-cyclopenta[b]benzofuran lignans isolated from Aglaia elliptica. Chem.-Biol. Interact., 115, 215-228 (1998).
7. Phillips, R. M., Inhibition of DT-diaphorase [NAD(P)H: quinone oxidoreductase, EC 1.6.99.2] by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and flavone-8-acetic acid (FAA): implications for bioreductive drug development. Biochem. Pharmacol., 58, 303-310 (1999).
8. Rao, K. V. and Beach, J. W., Streptonigrin and related compounds 5. Synthesis and evaluation of some isoquinolin analogues. J. Med. Chem., 34, 1871-1879 (1991).
9. Rao, K. V. and Rock, C. P., Streptonigrin and related compounds. 6. Synthesis and activity of some quinoxaline analogues. J. Heterocycl. Chem., 33, 447-458 (1996).
10. Ryu, C. K., Lee, I. K., Jung, S. H. and Lee, C. O., Synthesis and cytotoxic activities of 6-chloro-7-arylamino-5,8-isoquinolinediones. Bioorg. Med. Chem. Lett., 9(8), 1075-1080 (1999).
11. Ryu, C. K., Lee, Kang, H. Y., Lee, S. K., Nam, K. A., Hong, C. Y., Ko, W. G. and Lee, B. H., 5-Arylamino-2-methyl-4,7-dioxobenzothiazoles as inhibitors of cyclindependent kinase 4 and cyctotoxic agents. Bioorg. Med. Chem. Lett., 10(5), 461-464 (2000)
12. Shaikh, I. A., Johnson, F. and Grollman, A. P., Structure-activity relationship among simple bicyclic analogues. Rate dependent of DNA degradation on quinone reduction potential. J. Med. Chem., 29, 1329-1340 (1986).
13. Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, T. W., Bokesch, H., Kenney, S. and Boyd, M. R., New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst., 82, 1107-1112 (1990).